

Looking for Someone to Guide You.Search Here!!!




- All Posts
- AMC

AUM ₹ 919,519.99 crore (as on 31-Mar-2024) No. of schemes 116…

AUM ₹ 3,56,286 Cr (As on Apr 2024) No. of schemes 106…

AUM ₹ 2,92,118 Cr (As on Apr 2024) No. of schemes…

AUM ₹ 145302 Cr (As on Dec 2023) No. of schemes…
Premium Listing

ARGHA CHOWDHURY
0.0Listings
Top Categories
Blogs
- April 30, 2026
- by admin
Top Investment Options India for Beginners
- April 14, 2026
- by admin
SIP vs Lump Sum Investment – Which is Better in India (2026 Guide)
- February 11, 2026
- by admin
Simple Ways To Improve Your Money Over Time
Market News
- Kalyan Jewellers Q1 Results: Net profit jumps 32% YoY to ₹349 crore; margins contract
Kalyan Jewellers reported a net profit of ₹348 crore for the June quarter, a 32% YoY increase. However, it declined sequentially from ₹409 crore. Revenue rose 46% YoY to ₹10,589 crore, but fell 3% QoQ, with lower contribution from studded jewellery.
- Bharti Airtel Q1 Results: Profit climbs on higher subscriber upgrades, robust data usage
Bharti Airtel reported a consolidated net profit of ₹8,167 crore for Q1FY27, a 37.3% YoY increase, announced on August 04. However, net profit declined 11.5% compared to ₹7,325 crore in Q4FY26.
- Bharti Airtel Q1 results: Net profit jumps 37% to ₹8,167 crore; revenue up 18% - Key highlights
Bharti Airtel announced its Q1FY27 earnings, reporting a 37% rise in net profit to ₹8,167 crore and an 18.3% increase in revenue to ₹58,539 crore, compared to the previous year.
- Penny stock under ₹10 jumps 3.50% from today's low; here's why
PC Jeweller's promoters increased their shareholding to 38.76% following a preferential allotment of shares. The company's outstanding debt has been cleared for seven out of fourteen consortium banks, as it progresses towards a debt-free status.
- Sun Pharma’s premium push cushions US generics pain in Q1, but valuations look full
India formulations and innovative medicines drive growth in Q1FY27, with management reiterating FY27 guidance. Margins face near-term pressure from investments and the Organon acquisition.






































